Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
作者信息
Zhang Baoyuan, Li Ning, Gao Jiaming, Zhao Yuxi, Jiang Jun, Xie Shuang, Zhang Cuiping, Zhang Qingyu, Liu Leo, Wang Zaiqi, Ji Dongmei, Wu Lingying, Ren Ruibao
机构信息
State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
J Exp Clin Cancer Res. 2024 Apr 16;43(1):113. doi: 10.1186/s13046-024-03033-8.
Abstract
摘要
相似文献
1
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
J Exp Clin Cancer Res. 2024 Apr 16;43(1):113. doi: 10.1186/s13046-024-03033-8.
2
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
J Exp Clin Cancer Res. 2024 Feb 19;43(1):51. doi: 10.1186/s13046-024-02974-4.
3
Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy.
Biomaterials. 2023 Oct;301:122278. doi: 10.1016/j.biomaterials.2023.122278. Epub 2023 Aug 14.
4
Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.
ACS Appl Mater Interfaces. 2021 Sep 22;13(37):43963-43974. doi: 10.1021/acsami.1c10643. Epub 2021 Sep 10.
5
Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
Int J Nanomedicine. 2023 Jun 9;18:3109-3124. doi: 10.2147/IJN.S408855. eCollection 2023.
6
Correction: Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response.
Nanoscale. 2021 Aug 28;13(32):13907. doi: 10.1039/d1nr90174e. Epub 2021 Aug 9.
7
Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Biomaterials. 2021 Feb;269:120638. doi: 10.1016/j.biomaterials.2020.120638. Epub 2020 Dec 30.
8
Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers.
Cancer Lett. 2023 May 28;562:216167. doi: 10.1016/j.canlet.2023.216167. Epub 2023 Apr 7.
9
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy.
J Nanobiotechnology. 2024 Mar 13;22(1):109. doi: 10.1186/s12951-024-02314-w.
10
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy.
Acta Pharm Sin B. 2022 Apr;12(4):2103-2119. doi: 10.1016/j.apsb.2021.10.010. Epub 2021 Oct 22.
本文引用的文献
1
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
J Exp Clin Cancer Res. 2024 Feb 19;43(1):51. doi: 10.1186/s13046-024-02974-4.
Zotero 插件